300+ investors in your industry, stage, and region Get
Any industry
Community
Proptech
Biotech
Climate
Artificial Intelligence
Media (Entertainment)
Impact
FinTech
Marketplace
EdTech
Consumer
Agriculture (AgTech)
Web3
Clean Energy
B2B
Organic Food
Big Data
Video Games
Payments
Celebrity
Franchise
Mobile
Local
Social Network
Platforms
Crowdfunding
CleanTech
Film
Theatre
Life Science
Non Profit
Transportation
Gaming
Energy
Hardware
Health Care
Enterprise
Sustainability
Venture Capital
Restaurants
Fashion
Real Estate
Retail
Infrastructure
Mobile Apps
Beauty
LGBT
Publishing
Sporting Goods
Oil and Gas
Education
Renewable Energy
Food and Beverage
Cryptocurrency
Finance
Financial Services
Photography
Art
Medical
Digital Media
Music
Internet
Social Media
Manufacturing
Facebook
Blockchain
Legal
Android
Social Impact
Google
Construction
Sports
eSports
Enterprise Software
Email
Wellness
Hospitality
Travel
Fitness
Mobile Advertising
Cannabis
Recruiting
Biotechnology
Medical Device
Wine and Spirits
Automotive
Social
InsurTech
SaaS
Software
Any country
Qatar
South Korea
Africa
Asia
LATAM
Europe
Oceania
Middle East
Ireland
Singapore
Indonesia
Spain
Saudi Arabia
Belarus
Belgium
Colombia
Denmark
Ecuador
Czech Republic
Estonia
Ghana
Ethiopia
Finland
Barbados
Italy
Jersey
Cayman Islands
Mali
Malaysia
Mauritius
Poland
Rwanda
Togo
Slovenia
San Marino
Tanzania
Thailand
Uruguay
Venezuela
Portugal
Azerbaijan
Namibia
Bolivia
Latvia
Cyprus
New Zealand
United States
Germany
Australia
India
United Kingdom
Canada
China
South Africa
Brazil
Japan
Sri Lanka
Vietnam
Argentina
Armenia
Austria
Bangladesh
Bahrain
Bulgaria
Bermuda
Chile
Cameroon
Switzerland
Belize
Costa Rica
Algeria
Georgia
Egypt
Hong Kong
Gibraltar
Faroe Islands
Greece
Croatia
France
Hungary
Kuwait
Israel
Lebanon
Cambodia
Kenya
Jordan
Lithuania
Liberia
Liechtenstein
Myanmar
Kazakhstan
Morocco
Norway
Mexico
Panama
Malta
Peru
Philippines
Nicaragua
Pakistan
Russian Federation
Romania
Sweden
Serbia
Seychelles
Turkey
Puerto Rico
Sierra Leone
Senegal
Tunisia
Tajikistan
El Salvador
Uganda
Zambia
Uzbekistan
Taiwan
Ukraine
Zimbabwe
Bahamas
Guatemala
Iraq
Iceland
Nigeria
United Arab Emirates
Honduras
Isle of Man
Luxembourg
Oman
Angel Investors
VC Funds
All Investors
Download Find emails Save list
Open database

Top 50 Life Science VC Funds & Investors in Middle East (October 2023)

The most active venture capital funds investing in Middle East Life Science startups. This investor list is updated monthly from the Shizune investor database, ranked by number of investments in Middle East Life Science startup companies. Find investors to raise a Seed, Series A or Series B round with Shizune.
Investor Relevant Deals Geography Stage Focus Round Size
TRANGELS
VC Fund
4 Turkey, United States, Estonia Seed, Pre-Seed, Angel Biotechnology, Energy, Manufacturing $29k–$1.4M
Egypt Ventures
VC Fund
4 Egypt, United States, The Netherlands Seed, Pre-Seed, Series A Software, Information Technology, E-Commerce $28k–$3M
Integra Holdings
VC Fund
4 Israel Seed, Series B, Series F Biotechnology, Pharmaceutical, Life Science
Israel Innovation Authority
VC Fund
3 Israel, United States, Mali Grant, Seed, Pre-Seed Health Care, Medical Device, Software $91k–$4M
OrbiMed
VC Fund
3 United States, China, Israel Series B, Series A, Series C Biotechnology, Health Care, Pharmaceutical $10M–$120M
Pitango VC
VC Fund
3 Israel, United States, China Series A, Series B, Series C Software, Health Care, Information Technology $2M–$42M
Neo Ventures
VC Fund
3 Israel, United Kingdom, Estonia Seed, Series A Software, Artificial Intelligence, Aerospace $1.1M–$1.6M
Sapir Venture Partners
VC Fund
3 Israel, United States, United Kingdom Seed, Pre-Seed, Series A Software, Biotechnology, Machine Learning $1.3M–$5M
Endure Capital
VC Fund
2 Egypt, United States, United Kingdom Seed, Series A, Series B Health Care, Software, E-Commerce $225k–$34M
Genesis Park
VC Fund
2 United States, Israel Private Equity, Debt Financing Manufacturing, Health Care, Natural Resources $2.5M–$200M
Takeda Ventures
VC Fund
2 United States, United Kingdom, Israel Series A, Series B Biotechnology, Health Care, Therapeutics $8M–$100M
Johnson & Johnson Robotics and Digital Solutions
VC Fund
2 United States, Israel, United Kingdom Series A, Series B, Series C Biotechnology, Health Care, Medical $300k–$80M
Cancer Focus Fund
VC Fund
2 Israel Series A Biotechnology, Medical, Life Science
Cairo Angels
VC Fund
2 Egypt, United States, Lebanon Seed, Angel, Pre-Seed E-Commerce, Mobile, Marketplace $50k–$3M
fresh.fund
VC Fund
2 Israel, United States, Norway Pre-Seed, Seed, Series A Health Care, FinTech, E-Learning $300k–$8M
LoftyInc Capital Management
VC Fund
2 United States, Nigeria, Egypt Seed, Pre-Seed, Series A FinTech, Financial Services, Software $100k–$15M
Pontifax
VC Fund
2 United States, Israel, France Series A, Series B, Series C Biotechnology, Health Care, Therapeutics $3.8M–$100M
Averroes Ventures
VC Fund
2 Egypt, United Arab Emirates Seed, Convertible Note Transportation, Logistics, Delivery $500k–$1.4M
FutuRx
VC Fund
2 Israel Health Care, Biotechnology, Pharmaceutical
Life Science Angels
VC Fund
1 United States, Israel, The Netherlands Seed, Series A Biotechnology, Health Care, Medical $605k–$20M
Sectoral Asset Management
VC Fund
1 United States, United Kingdom, France Series B, Series C, Post-IPO Equity Biotechnology, Health Care, Medical $20M–$230M
Arkin Holdings
VC Fund
1 Israel, United States, Switzerland Series A, Seed Biotechnology, Health Care, Medical Device $5.5M–$20M
Morningside Venture Investments
VC Fund
1 United States, United Kingdom, China Series A, Series B, Series C Biotechnology, Health Care, Medical $6M–$67M
Angel
VC Fund
1 United States, United Kingdom, Singapore Pre-Seed, Seed, Series A Software, Information Technology, Artificial Intelligence
OTV
VC Fund
1 United States, Israel, Ghana Series A, Series B, Seed Health Care, Medical, Artificial Intelligence $5M–$50M
Arc Impact
VC Fund
1 Israel, United States, United Kingdom Seed, Pre-Seed Health Care, AgTech, EdTech $2.5M–$6M
Alexandria Fund
VC Fund
1 Egypt Seed Biopharma, Life Science, Biotechnology
M Ventures
VC Fund
1 United States, Switzerland, United Kingdom Series A, Series B, Seed Biotechnology, Health Care, Therapeutics $2.1M–$67M
Office of the Chief Scientist
VC Fund
1 Israel Seed Health Care, Biotechnology, Hardware $1M–$1M
RMGP Biopharma Investment Fund
VC Fund
1 Israel Series B Biotechnology, Health Care, Pharmaceutical
Milk and Honey Investments
VC Fund
1 Israel Series A Life Science, Organic Food, Biotechnology
Emirates Angels
VC Fund
1 United Arab Emirates Pre-Seed Health Care, Life Science
Aries Holding BV
VC Fund
1 The Netherlands, Israel Seed, Pre-Seed FinTech, Finance, Payments
Stony Hill Corp
VC Fund
1 Israel Series A AgTech, Medical, Cannabis
Arba Finance Ltd.
VC Fund
1 Israel Series A AgTech, Medical, Cannabis
Nowaisi Investments
VC Fund
1 United Arab Emirates Pre-Seed Health Care, Life Science
Grove Ventures
VC Fund
1 Israel, United States Seed, Series A, Series B Artificial Intelligence, Machine Learning, Software $3.3M–$74M
Hult Alumni Angels
VC Fund
1 Egypt Seed Biopharma, Life Science, Biotechnology
Jerusalem Venture Partners (JVP)
VC Fund
1 United States, Israel, United Kingdom Series A, Series B, Seed Software, Cyber Security, Enterprise Software $1.5M–$25M
aMoon Fund
VC Fund
1 United States, Israel, United Kingdom Series A, Series B Biotechnology, Health Care, Medical $6M–$63M
NextLeap Ventures
VC Fund
1 Israel, United States Seed, Series A Software, Big Data, Health Care $900k–$5M
Trendlines Group
VC Fund
1 Israel, Singapore, United Kingdom Seed, Series A Health Care, Biotechnology, Medical Device $500k–$7.5M
Clal Biotechnology Industries
VC Fund
1 Israel, United States Series A, Series B Biotechnology, Health Care, Medical $4M–$55M
Alex Angels
VC Fund
1 Egypt Seed, Pre-Seed, Convertible Note E-Commerce, Marketplace, Mobile Apps $28k–$1.2M
First Star Ventures
VC Fund
1 United States, Canada, Israel Seed, Pre-Seed, Series A Software, Artificial Intelligence, Machine Learning $895k–$13M
Ibtikar Fund
VC Fund
1 Palestinian Territory, United States, Jordan Seed, Pre-Seed E-Commerce, Artificial Intelligence, Health Care $60k–$600k
HBL Hadasit Bio Holdings
VC Fund
1 Israel Series A, Series B Biotechnology, Medical, Health Care
Forbion Capital Partners
VC Fund
1 United States, United Kingdom, The Netherlands Series B, Series A, Series C Biotechnology, Health Care, Medical $4.5M–$115M
Almoayed Ventures
VC Fund
1 United States, India, United Arab Emirates Seed, Series A, Pre-Seed Health Care, Information Technology, Financial Services $1.2M–$13M
Boehringer Ingelheim Venture Fund
VC Fund
1 United States, Germany, Belgium Series A, Series B, Seed Biotechnology, Health Care, Therapeutics $1.3M–$50M
Access all 50 VC funds in Middle East Life Science startups.

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Investor list

TRANGELS
VC Fund · Istanbul, Istanbul, Turkey · 4 investments in Middle East Life Science startups

Early Stage Investment Fund and Network

Show more...

Investment focus

  • Industry: Biotechnology, Energy, Manufacturing
  • Stage:Seed, Pre-Seed, Angel
  • Geography: Turkey, United States, Estonia

Investor stats

  • Total investments: 31
  • Round size: Seed $67k–$1.4M; Angel $29k–$500k; Pre-Seed $35k–$400k
  • Lead/follow: 29% lead, 71% follow

Portfolio highlights

  • & New Me — Andnewme is a health platform that serves with the motto "only aesthetics". You can get information about aesthetic treatments and find the doctor you are looking for!
  • Biftek — The future of meat starts here. We produce growth medium to make cultured meat affordable.
  • Nanomik Biotechnology — Nanomik Biotechnology produces next generation biofungicides that increase the shelf life of fresh fruits and vegetables. Antimicrobial raw materials produced by microorganisms isolated from nature and active molecules obtained from plants are placed in micro-sized biopolymer capsules and applied to fruits. These completely natural microcapsulesadhere to the fruit and open within 24-48 hours and provide protection on the surface. While the biopolymer material forms an edible layer on the fruit, the ingredients in it prevent the growth of molds present in the medium. Unlike chemical fungicides, our products do not cause any harm to human and environment.
Show all investments...

Egypt Ventures
VC Fund · El Cairo, Valle del Cauca, Colombia · 4 investments in Middle East Life Science startups

Egypt Ventures is an investment firm that empowers the entrepreneurial ecosystem by investing in accelerators. The firm was founded in 2017 and is based in Columbia.

Show more...

Investment focus

  • Industry: Software, Information Technology, E-Commerce
  • Stage:Seed, Pre-Seed, Series A
  • Geography: Egypt, United States, The Netherlands

Investor stats

  • Total investments: 20
  • Round size: Seed $100k–$3M; Pre-Seed $28k–$2M
  • Lead/follow: 40% lead, 60% follow

Portfolio highlights

  • MNT-Halan — MNT-Halan is a microfinance lending and payments company.
  • Gahez Market — Gahez Market Online store
  • Synapse Analytics — We build data science and AI solutions for streamlined operations and data driven decisions. Synapse Analytics, enabling a smarter world.
Show all investments...

Integra Holdings
VC Fund · Wallisellen, Zurich, Switzerland · 4 investments in Middle East Life Science startups

Our expert team is the first to examine and evaluate the Hebrew University's biomedical breakthroughs. We then capitalize decades of experience - transforming the inventions into pioneering companies. Our golden eggs Ayana Pharma A late stage company with

Show more...

Investment focus

  • Industry: Biotechnology, Pharmaceutical, Life Science
  • Stage:Seed, Series B, Series F
  • Geography: Israel

Investor stats

  • Total investments: 8
  • Lead/follow: 75% lead, 25% follow

Portfolio highlights

  • BacoCure — BacoCure is developing a novel bacterial product for local therapy of non-muscle invasive bladder cancer (NMIBC) patients.
  • Splisense — Splisense is develops antisense oligonucleotide based therapies to target genetic diseases caused by splicing mutations. The company has developed a compound to cure the lung disease in cystic fibrosis patients carrying a specific splicing mutation. It is also developing a targeted modulation approach to correct the splicing pattern of CFTRtranscripts according to the specific mutation carried.
  • Rebiotic Rx — Develops nanotechnology-based antibiotics with the focus on resistant bacteria
Show all investments...

Israel Innovation Authority
VC Fund · Jerusalem, Yerushalayim, Israel · 3 investments in Middle East Life Science startups

The Israeli innovation agency, the Innovation Authority, was established in 1965 as the Office of the Chief Scientist of the Ministry of Industry and Trade and was designed as a body that supports R & D conducted in the framework of government research institutes. Industrial development in order to increase industrial exports of high-techproducts. The Chief Scientist focused on reducing the risk by participating in financing the project, which the private companies chose and led.

Show more...

Investment focus

  • Industry: Health Care, Medical Device, Software
  • Stage:Grant, Seed, Pre-Seed
  • Geography: Israel, United States, Mali

Investor stats

  • Total investments: 107
  • Round size: Seed $500k–$4M; Grant $91k–$2.5M; Pre-Seed $150k–$1M
  • Lead/follow: 40% lead, 60% follow

Portfolio highlights

  • Enzymit — Enzymit's platform technology can build molecular machines that enable never before seen chemistry aiming to solve humanity's greatest challenges
  • BloomX — Helping nature do its magic with the power of technology
  • MICA — MICA save lives & improve life quality. Our approach to the environmental and social dimensions is reflected in our commitment to United Nations Sustainable
Show all investments...

OrbiMed
VC Fund · New York, New York, United States · 3 investments in Middle East Life Science startups, 38 in the past 12 months

Leading Global Healthcare Platform with Deep Proprietary Resources and Global Industry Coverage.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Pharmaceutical
  • Stage:Series B, Series A, Series C
  • Geography: United States, China, Israel

Investor stats

  • Total investments: 419
  • Round size: Series A $10M–$102M; Series B $23M–$120M; Series C $12M–$108M
  • Lead/follow: 36% lead, 64% follow
  • Last fund: Likely still investing — fund raised in 2023

Portfolio highlights

  • Evozyne — We have a new way of thinking about proteins. We've uncovered Nature's hidden rules to build Natural Machines. With our partners, we are changing the world.
  • Adela — Adela is focused on the detection of cancer and other high-morbidity, high-mortality conditions through a blood test.
  • Iambic Therapeutics — Iambic has created a cutting-edge AI-driven platform to tackle the most challenging design problems in drug discovery and address unmet patient need.
Show all investments...

Pitango VC
VC Fund · Herzliya, Tel Aviv, Israel · 3 investments in Middle East Life Science startups, 20 in the past 12 months

Pitango VC is a venture capital firm focused on health-tech (Pitango Health-tech) and growth (Pitango Growth) investments in startups around the world in domains such as vertical SaaS, digital health, deep tech, fintech and insurance technology, devops, generative AI, Web3, and food tech.With two offices in Israel, Pitango currently managesseveral venture funds totaling over $2.8 billion in committed capital. It has invested in more than 250 companies.

Show more...

Investment focus

  • Industry: Software, Health Care, Information Technology
  • Stage:Series A, Series B, Series C
  • Geography: Israel, United States, China

Investor stats

  • Total investments: 243
  • Round size: Series A $2M–$25M; Series B $7M–$35M; Series C $7.5M–$42M
  • Lead/follow: 36% lead, 64% follow
  • Last fund: Likely still investing — fund raised in 2023

Portfolio highlights

  • AI21 Labs — AI21 Labs is an AI lab & product company whose mission is to reimagine the way we read and write by making the machine a thought partner to humans.
  • QuantHealth — QuantHealth is an AI company that provides a platform to simulate clinical trials in order to accelerate and de-risk drug development.
  • Gina Life — At Nevia bio, we are focused on women's health. Our mission is to use innovative technologies to provide early detection of diseases through vaginal secretions analysis, enabled by Nevia's Machine Learning Platform.
Show all investments...

Neo Ventures
VC Fund · Sofia, Grad Sofiya, Bulgaria · 3 investments in Middle East Life Science startups

Neo Ventures is the first open-ended early stage investor, based in Eastern Europe. The founders have backed more than 30 startups and exited 10 successfully. We invest in game-changing businesses, without geographic limitations. We partner with exceptional founder teams to challenge incumbents in markets ripe for change or to create entirely newmarkets. Neo Ventures funds and then supports the founders in business planning, scaling operations, follow-on investments, making the best of each opportunity and dealing with hard situations. Our investment focus is on data analytics, computer vision and remote sensing addressing disruptive opportunities across the high-growth SpaceTech, BioTech and Security verticals.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Aerospace
  • Stage:Seed, Series A
  • Geography: Israel, United Kingdom, Estonia

Investor stats

  • Total investments: 13
  • Round size: Seed $1.1M–$1.6M
  • Lead/follow: 31% lead, 69% follow

Portfolio highlights

  • EnduroSat — EnduroSat designs, builds and operates class-leading NanoSats for a range of commercial, exploration and science missions. We focus on inter-satellite connectivity and space data applications
  • Cyberwrite — TRUSTED BY INDUSTRY LEADERS One platform to accelerate value across the cyber insurance lifecycle THE LATEST FROM CYBERWRITE
  • GemmaCert — The easy-to-use GC-PRO by GemmaCert for quick and accurate potency analysis of cannabis and hemp, including for THC, CBD, and CBG.
Show all investments...

Sapir Venture Partners
VC Fund · 3 investments in Middle East Life Science startups

Early Stage VC

Show more...

Investment focus

  • Industry: Software, Biotechnology, Machine Learning
  • Stage:Seed, Pre-Seed, Series A
  • Geography: Israel, United States, United Kingdom

Investor stats

  • Total investments: 18
  • Round size: Seed $1.3M–$5M
  • Lead/follow: 22% lead, 78% follow

Portfolio highlights

  • Enzymit — Enzymit's platform technology can build molecular machines that enable never before seen chemistry aiming to solve humanity's greatest challenges
  • DeepCure — Pioneering a new frontier in drug development. DeepCure is building an AI engine for small-molecule drug discovery.
  • Genetika+ — Genetika+ is revolutionzing depression treatment. Using biological, medical and genetic data, GenetikaPlus develops personalized solution for every patient to help them recover better, faster.
Show all investments...

Endure Capital
VC Fund · Cairo, Al Qahirah, Egypt · 2 investments in Middle East Life Science startups

Endure Capital is an early stage investment fund headed by entrepreneurs looking for startup teams. They look for founders who are relentlessly resourceful and imaginative, solving genuine problems that matter to a lot of people and building high growth companies that endure.

Show more...

Investment focus

  • Industry: Health Care, Software, E-Commerce
  • Stage:Seed, Series A, Series B
  • Geography: Egypt, United States, United Kingdom

Investor stats

  • Total investments: 59
  • Round size: Seed $225k–$6.4M; Series A $1M–$34M; Series B $6M–$14M
  • Lead/follow: 27% lead, 73% follow
  • Last fund: Likely still investing — raised $50M in 2022

Portfolio highlights

  • Suplyd — Suplyd is a comprehensive digital solution that bridges the gap between restaurant operators and their suppliers in order to disrupt an untouched market with extreme fragmentation and resolve the problem end-to-end.
  • Pylon — Pylon provides water and electricity distribution companies, in emerging markets, with a platform for managing their customers and infrastructure.
  • Almentor — almentor.net is a cutting-edge continuous e-learning platform curating top-rated video-based training programs delivered by leading subject matter experts and accessible through B2C and B2B channels to serve the needs of Arabs across the world. The platform was officially launched in January 2018 and currently offers the biggest Arabic high qualitycontinuous learning video library in the world, including paid courses, free talks, crash courses and books, primarily in Arabic.
Show all investments...

Genesis Park
VC Fund · Houston, Texas, United States · 2 investments in Middle East Life Science startups

Genesis Park is a Houston-based private equity firm focusing on buyouts, partnering strategies with public corporations, and growth financing. We bring capital, commercial execution capabilities and a depth of experience in mergers and acquisitions.We are opportunistic within market sectors where we have depth and exposure. Those sectors includetelecommunications, energy technology and media. Energy technology is a rapidly expanding category, and our Houston base allows us to marry traditional and alternative techniques in upstream and downstream environments. Founded in 2000, Genesis Park has used discipline and patience to build value for our investors, regardless of prevailing market conditions. We are consistently active in our portfolio companies, listening, learning and adding value by working alongside management. While our preference is to partner with an existing management team, we commonly source additional talent to optimize the existing opportunity.

Show more...

Investment focus

  • Industry: Manufacturing, Health Care, Natural Resources
  • Stage:Private Equity, Debt Financing
  • Geography: United States, Israel

Investor stats

  • Total investments: 16
  • Round size: Debt Financing $5.5M–$65M; Private Equity $2.5M–$200M
  • Lead/follow: 56% lead, 44% follow
  • Last fund: Likely still investing — fund raised in 2021

Portfolio highlights

  • The Good Feet Store — Good Feet has been helping people with foot problems feel better and get back to living their lives. Personally fit with the arch support that meets their needs. Contact us now to see the available Good Feet Arch Support!
  • WESTCO GROUNDS — Westoco Provides Landscaping is a highly competitive industry, and Westco continues to thrive because it tailor services to specific client needs and deliver complete solutions with dependability,Rainbird facilitate quick responses and ressources.
  • Le Sueur Incorporated — Le Sueur Incorporated is a mining & metals company offering sand casting, permanent mold, and die casting.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Takeda Ventures
VC Fund · San Diego, California, United States · 2 investments in Middle East Life Science startups, 6 in the past 12 months

Takeda Ventures, Inc. (TVI) is the corporate investment arm of Takeda Pharmaceutical Company Limited (TPC). TVI was founded in 2001 and invests in current and future areas of interest for TPC. They are based alongside Takeda’s R&D sites in Cambridge, MA, and San Diego, CA. As a strategic investor, TVI aims to provide support and guidance toentrepreneurs and early-stage companies driving concepts through clinical proof of concept. They also strive to forge active, collaborative interactions that result in synergies with Takeda's considerable R&D resources. Their goal is to build a portfolio of strategic investments, with an immediate emphasis on oncology, gastroenterology, neuroscience, and rare diseases.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series A, Series B
  • Geography: United States, United Kingdom, Israel

Investor stats

  • Total investments: 95
  • Round size: Series A $8M–$43M; Series B $11M–$100M
  • Lead/follow: 19% lead, 81% follow

Portfolio highlights

  • Cerevance — Cerevance is a developer of novel therapeutics intended to advance new medicines for serious neurological diseases.The company's therapeutics applies it's technology called NETSseq to reveal transcriptional and epigenetic differences between specific cell types in mature human brains, enabling healthcare providers to detect and tackle theearly onset of various neurological diseases.
  • OncoResponse — OncoResponse Inc., an immuno-oncology company located in Houston, Texas, has partnered with MD Anderson Cancer Center (MDACC) to deploy a unique and transformational approach to cancer therapeutic monoclonal antibody and target discovery. The company licensed the I-STAR™ platform, developed and validated by Theraclone Sciences of Seattle, tointerrogate the human memory B-cell repertoire of cancer patients who are considered “Elite Responders” to immunotherapy; as such, their own adaptive immune system responded to immunotherapy stimulation in a way that achieved curative or durable responses. From these Elite Responders, OncoResponse is leveraging the human immune system to identify fully human monoclonal antibodies and discover novel targets that will lead to the development of fully human antibody derived therapeutics for the treatment of cancer.
  • Larkspur Biosciences — Larkspur's strategy focuses on the particular ways in which tumours hijack the immune system by developing precision immunotherapies for molecularly defined patient groups to overcome the bottlenecks that allow the tumour to subvert the immune system.
Show all investments...

Johnson & Johnson Robotics and Digital Solutions
VC Fund · New Brunswick, New Jersey, United States · 2 investments in Middle East Life Science startups

Healthcare innovation wherever it originates.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Series B, Series C
  • Geography: United States, Israel, United Kingdom

Investor stats

  • Total investments: 69
  • Round size: Series A $5.9M–$65M; Series B $7.5M–$80M; Series C $300k–$70M
  • Lead/follow: 23% lead, 77% follow

Portfolio highlights

  • Moon Surgical — MastOR is a medical device company developing a surgical robot for laparoscopy assistance. MastOR is an early-stage surgical robotics company whose laparoscopy assistance platform broadens access to minimally-invasive techniques for surgeons and optimizes resource utilization in the operating room.
  • ArteraAI — Discover the power of Personalized Precision Medicine & AI Cancer Therapy with ArteraAI. Transforming cancer therapy through innovation.
  • Nucleome Therapeutics — Decoding the dark matter of the human genome to deliver first-in-class precision medicinesDiscover More
Show all investments...

Cancer Focus Fund
VC Fund · 2 investments in Middle East Life Science startups

Cancer Focus Fund is an investment firm that is dedicated to providing financial services to its clients. The company was founded by Ross Barrett.

Show more...

Investment focus

  • Industry: Biotechnology, Medical, Life Science
  • Stage:Series A
  • Geography: Israel

Investor stats

  • Total investments: 3
  • Lead/follow: no public data

Portfolio highlights

  • KAHR medical — KAHR Medical ("KAHR") is pioneering the development of "third generation biological drugs," a unique class of proprietary fusion-protein molecules with clear and far-reaching advantages. KAHR's technology represents a paradigm shift in protein-based pharmaceuticals that will significantly expand available treatment optionsfor cancer and autoimmune disorders.
  • Nectin Therapeutics — NectinTX is a biotech company focused on unlocking the power of the immune system by developing a collection of next-gen immunotherapy agents.
Show all investments...

Cairo Angels
VC Fund · Cairo, Al Qahirah, Egypt · 2 investments in Middle East Life Science startups

Cairo Angels is an angel investment network that invests in and supports early-stage startups it convenes regular investment meetings to review pre-selected potential investees.

Show more...

Investment focus

  • Industry: E-Commerce, Mobile, Marketplace
  • Stage:Seed, Angel, Pre-Seed
  • Geography: Egypt, United States, Lebanon

Investor stats

  • Total investments: 31
  • Round size: Seed $50k–$3M; Angel $200k–$300k
  • Lead/follow: 42% lead, 58% follow

Portfolio highlights

  • Nawah Scientific — Nawah is MENA & Africa's first Cloud Lab providing Analytical and R&D services to the region's life science, food, agricultural and pharmaceutical sectors.
  • Sprints — home page Description
  • The Fashion Kingdom — Fashion, Sneakers for men, women, and kids
Show all investments...

fresh.fund
VC Fund · Jerusalem, Yerushalayim, Israel · 2 investments in Middle East Life Science startups

fresh.fund is an Israeli pre-seed venture capital fund investing in early-stage startups across segments and verticals.We're built to partner with early-stage founders from day one, often as the company's first institutional investors. Our model is refreshingly simple: up to $300,000 in pre-seed funding within <4 weeks and follow-oncapital as necessary.Check out our portfolio here >> https://www.fresh.fund/portfolio. It's never too early to have a conversation about your startup.

Show more...

Investment focus

  • Industry: Health Care, FinTech, E-Learning
  • Stage:Pre-Seed, Seed, Series A
  • Geography: Israel, United States, Norway

Investor stats

  • Total investments: 19
  • Round size: Seed $1.6M–$8M; Pre-Seed $300k–$760k
  • Lead/follow: 21% lead, 79% follow

Portfolio highlights

  • Wisor — Propelling the supply chain industry into the digital age Wisor is a plug & play solution that provides a global automated quoting solution that allows freight forwarders to generate quotes and communicate with clients automatically Get a demo What took days now takes minutes Wisor is specifically designed to support and simplify the complexity of generating quotes
  • Peech — Peech, an automatic video editing tool, analyzes the verbal content of your video, edits it into a short & catchy version and enhances it with suited visual elements that attract your audience.
  • Ritual — Couple Goals Made Possible. Relationship Support For Busy People, Practical Tools & Expert Feedback
Show all investments...

LoftyInc Capital Management
VC Fund · Carmel, California, United States · 2 investments in Middle East Life Science startups

LoftyInc Capital Management empowers Afropreneurs to build a prosperous and equitable future in Africa. We deliver value to both founders and investors.........

Show more...

Investment focus

  • Industry: FinTech, Financial Services, Software
  • Stage:Seed, Pre-Seed, Series A
  • Geography: United States, Nigeria, Egypt

Investor stats

  • Total investments: 111
  • Round size: Seed $100k–$3.2M; Pre-Seed $100k–$2M; Series A $250k–$15M
  • Lead/follow: 14% lead, 86% follow
  • Last fund: Likely still investing — fund raised in 2021

Portfolio highlights

  • Craydel — Get Professional career guidance based on Psychometric Assessments and get scholarships to the best MBA, Engineering, Medical, Education online and on campus courses in Africa and Abroad.
  • EMTECH — For Modern Central Banking
  • Terragon Group — Terragon is a leading Data and Marketing Technology company that uses data and analytics to help companies focused in Africa, intelligently connect at scale to their customers. We use an aggregation of online and offline data, and predictive scoring to help brands, marketing agencies and platforms accurately target people across channels anddevices. Headquartered in Lagos; Nigeria, we also have a presence in Kenya, South Africa, Ghana and India.
Show all investments...

Pontifax
VC Fund · Herzliya, Tel Aviv, Israel · 2 investments in Middle East Life Science startups

Pontifax is a healthcare-dedicated venture capital firm.The fund focuses on innovative bio-pharma opportunities.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series A, Series B, Series C
  • Geography: United States, Israel, France

Investor stats

  • Total investments: 93
  • Round size: Series A $3.8M–$72M; Series B $16M–$100M; Series C $12M–$75M
  • Lead/follow: 23% lead, 77% follow
  • Last fund: May invest from a new fund soon — last raise in 2020

Portfolio highlights

  • Abcuro — Precision Targeting of Highly Cytotoxic T Cells in Autoimmune Disease.
  • Precirix — Developing radio-immunotherapeutic drugs for cancer patients.
  • ARMGO,Pharma,Inc. — ARMGO Pharma, Inc., a biopharmaceutical company, develops small-molecule therapeutics to treat debilitating cardiac, skeletal muscular, and neurological disorders. It offers rycals, which are calcium release channel stabilizers that act on ryanodine receptor/calcium release channel, a therapeutic target located on thesarcoplasmic/endoplasmic reticulum of the cell for treating chronic heart failure, cardiac arrythmias, and muscle disorders, as well as cognitive disorders, malignant hyperthermia, diabetes, chronic obstructive pulmonary disease, high blood pressure, and bladder dysfunction. The company was incorporated in 2004 and is based in Tarrytown, New York with an additional office in New York, New York.
Show all investments...

Averroes Ventures
VC Fund · Cairo, Al Qahirah, Egypt · 2 investments in Middle East Life Science startups

Averroes Ventures helps and invests in entrepreneurial teams seeking to transform big ideas into game-changing companies. Averroes Ventures' team possesses years of combined experience in global business operation and management across a multitude of sectors to help achieve visions.

Show more...

Investment focus

  • Industry: Transportation, Logistics, Delivery
  • Stage:Seed, Convertible Note
  • Geography: Egypt, United Arab Emirates

Investor stats

  • Total investments: 5
  • Round size: Seed $500k–$1.4M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • ILLA — Digital trucking and delivery platform powered by reliable drive to enable businesses with different volumes handle and optimize their trucking and logisitcs processes effeciently.
  • Nawah Scientific — Nawah is MENA & Africa's first Cloud Lab providing Analytical and R&D services to the region's life science, food, agricultural and pharmaceutical sectors.
  • Khazenly — Khazenly is an on-demand digital warehousing and fulfillment management platform that provides an omnichannel solution to help merchants digitize their businesses.
Show all investments...

FutuRx
VC Fund · Ness Ziona, HaMerkaz, Israel · 2 investments in Middle East Life Science startups

FutuRx is the Israeli biotechnology accelerator that was established in 2014 by OrbiMed Israel Partners, Johnson & Johnson Innovation and Johnson & Johnson Development Corporation (JJDC) and Takeda Ventures Inc. following winning the tender of the Office of the Chief Scientist (OCS), Ministry of Economy, in Israel.The incubator willadvance new biotechnology products by identifying and nurturing early-stage life science innovation.FutuRx is located in the Weizmann Science Park in Ness Ziona (near the Weizmann Institute), Israel.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Pharmaceutical
  • Geography: Israel

Investor stats

  • Total investments: 3
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Ramino Bio — Ramino Bio is a private biotech company that develops an oral drug to treat metabolic diseases.Ramino has received funding totaling about $3.3 million since its beginning from the FutuRx biotech incubator, which is supported by the Israeli Innovation Authority, Takeda, J&J, OrbiMed, and RMPG. By speeding up their disintegration, our exclusivetechnology lowers the extra BCAA that is floating around.
  • Protekt Therapeutics — ProteKt Therapeutics is a drug development company aiming to develop potent and selective oral inhibitors of the kinase PKR for the treatment of neurodegenerative and neuroinflammatory diseases. The company has raised a $4M pre-A round and graduated from the FutuRx accelerator in 2019.
  • Bsense Bio Therapeutics — Bsense Bio Therapeutics is developing small molecules for the treatment of neuropathic pain. Bsense is pioneering a novel approach targeting multiple pain-related mechanisms using a single compound, to achieve greater efficacy and safety.
Show all investments...

Life Science Angels
VC Fund · Sunnyvale, California, United States · 1 investments in Middle East Life Science startups

Life Science Angels, Inc. (LSA) is the premier angel investment group focused solely on healthcare investing, including medical devices, diagnostics, pharmaceuticals, biotechnology, and digital health.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Seed, Series A
  • Geography: United States, Israel, The Netherlands

Investor stats

  • Total investments: 78
  • Round size: Seed $605k–$4.1M; Series A $1.3M–$20M
  • Lead/follow: 9% lead, 91% follow

Portfolio highlights

  • InnoSIGN — We are passionate to bring to market our OncoSIGNal pathway activity profiling technology contributing to a better understanding of disease mechanisms in oncology. OncoSIGNal enables next generation precision medicine by translating molecular data into functional cell behavior.
  • Avisi Technologies — Avisi Technologies is developing a nanotechnology-enabled defense against blindness from glaucoma.
  • Astrocyte Pharmaceuticals — Astrocyte Pharmaceuticals Inc. is a privately held drug development company dedicated to accelerating the recovery and well-being of brain injury patients. The company is committed to proving the neuroprotective benefits of selective astrocyte activation, and advancing breakthrough therapeutic agents for treating brain injury resulting from stroke,TBI, concussion, and neurodegenerative disorders such as Alzheimer’s disease.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Sectoral Asset Management
VC Fund · Montréal, Quebec, Canada · 1 investments in Middle East Life Science startups

Sectoral is specialized in managing equities globally in the healthcare sector. Founded in October 2000, we are SEC-registered as an investment advisor. 100% employee-owned, we have offices in Montreal, Geneva, and Hong Kong.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series B, Series C, Post-IPO Equity
  • Geography: United States, United Kingdom, France

Investor stats

  • Total investments: 46
  • Round size: Series B $20M–$70M; Series C $40M–$80M; Post-IPO Equity $23M–$230M
  • Lead/follow: 27% lead, 73% follow
  • Last fund: May invest from a new fund soon — last raise in 2016

Portfolio highlights

  • Boundless Bio — Boundless Bio is a company that develops novel cancer therapeutics intended to understand and treat intraceable cancers. It aims to be the foremost biopharma company interrogating extrachromosomal DNA (ecDNA) biology to deliver transformative therapies to patients with previously intractable cancers.Boundless Bio was founded in 2018 and isheadquartered in La Jolla, California.
  • Miach Orthopaedics — Miach Orthopaedics is a medical device company that develops bio-engineered surgical implants to facilitate new tissue growth. The company's product is the Bridge-Enhanced ACL Repair technology as a viable alternative to conventional ACL reconstruction for patients who have withstand an anterior cruciate ligament injury.Miach Orthopaedicswas founded on 2016 and is headquartered in Westborough, Massachusetts.
  • Garuda Therapeutics — Garuda Therapeutics is developing off-the-shelf hematopoietic stem cell (HSC) therapies to treat a broad range of severe and life-threatening diseases.
Show all investments...

Arkin Holdings
VC Fund · Herzliya, Tel Aviv, Israel · 1 investments in Middle East Life Science startups

Arkin Holdings is dedicated to empowering companies that create breakthrough pharma, biotech, medical device, and digital health technologies. Our synergistic healthcare investments are focused on creating innovations that benefit humanity and enhance medical care. We offer extensive experience, with a track record of successful healthcareinvestments. Experts in the dynamic world of healthcare development, we provide the know-how and close accompaniment that helps our portfolio investments achieve substantial value and growth. Arkin Holdings currently has a healthcare portfolio of $1.5 billion through its 5 investment arms. Its investors include a substantial amount of Israel’s top-tier institutional investors.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical Device
  • Stage:Series A, Seed
  • Geography: Israel, United States, Switzerland

Investor stats

  • Total investments: 21
  • Round size: Seed $5.5M–$6M; Series A $18M–$20M
  • Lead/follow: 33% lead, 67% follow
  • Last fund: Likely still investing — fund raised in 2021

Portfolio highlights

  • Percepto — Percepto is a developer of autonomous drone technology for inspection and surveillance.Drones hold the potential to disrupt multi-billion dollar industries including energy, security, insurance, agriculture, and more. Drones completely change the way inspection, measurement, surveillance, and deliveries are done today. Still, the main barrier tomaking them a must-have platform is the ability of drones to perform tasks autonomously.The company is at the forefront of redefining how industrial sites and critical infrastructure are holistically inspected and monitored, harnessing remote robotics to autonomously collect, aggregate, and analyze visual data.Leveraging its experience with Percepto Sparrow, the most deployed drone-in-a-box solution on the market, Percepto introduced Percepto AIM (Autonomous Inspection and Monitoring) the first end-to-end autonomous inspection and monitoring platform. Percepto AIM empowers the remote operation center of the future to assess risk, minimize downtime, drive efficiency, increase safety, and reduce operational costs.
  • MadeRight — We usher in a new era of sustainable fungi-based materials that deliver excellent performance. The future, as we see it, is a novel industrial chain based on biomaterials.
  • Revamp Medical — Revamp medical was founded in 2016 with the goal of resolving one of the most urgent unmet needs in Acute Heart Failure patients. Targeting a market of >1M annual admissions in the US with a direct cost of $65B, Revamp is set to deliver an easily adoptable solution using its patented temporary catheter, Doraya™.Revamp has a seasoned team ofprofessionals with a proven track record in leading multiple med-tech startups.
Show all investments...

Morningside Venture Investments
VC Fund · Shanghai, Shanghai, China · 1 investments in Middle East Life Science startups

The Morningside group invests private-equity and venture capital in novel science and technology sectors and is committed to social responsibility.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Series B, Series C
  • Geography: United States, United Kingdom, China

Investor stats

  • Total investments: 90
  • Round size: Series A $6M–$42M; Series B $12M–$67M; Series C $9.2M–$40M
  • Lead/follow: 55% lead, 45% follow

Portfolio highlights

  • GaeaStar — The zero waste disposable clay cups. GaeaStar is an engineering company developing sustainable single use products and technology.
  • Phage Pharm — Phage Pharm is a professional enterprise in the industrialization of bacteriophages.
  • Epigenic Therapeutics — Epigenic Therapeutics is a biotech firm that offers gene editing therapy.
Show all investments...

Angel
VC Fund · 1 investments in Middle East Life Science startups, 8 in the past 12 months

Angel

Show more...

Investment focus

  • Industry: Software, Information Technology, Artificial Intelligence
  • Stage:Pre-Seed, Seed, Series A
  • Geography: United States, United Kingdom, Singapore

Investor stats

  • Total investments: 61
  • Lead/follow: no public data

Portfolio highlights

  • Vytal.ai — Vytal allows for brain health evaluation in minutes with just a laptop. Take control of your cognitive health.
  • Akhetonics — Creating the first all-optical RISC Processor
  • Greena World — In a world where travel connects us, we often overlook the impact we leave behind. Tourism accounts for over 8% of global CO2 emissions. Beyond environmental challenges like deforestation, pollution, and water scarcity, local communities also face pressure, experiencing changes in their traditions and ways of life.With expertise from SwanseaUniversity and the United Nations, our team recognised these challenges and envisioned a world where travel helps, not harms. Introducing Greena World. More than just a piece of technology, it's a guide for hotels and restaurants, helping them understand, improve, and share their impact on both the environment and local communities.The true beauty of embracing sustainability? The rewards. With the Greena Index, businesses can improve their sustainability and, in doing so, unlock a new market of over 100+ million eco-conscious travellers, boost revenues, and save on operating costs.The sustainable tourism sector is rapidly expanding, currently valued at $75B and witnessing a growth rate of 9.7% each year. While our initial focus is on hotels and restaurants, the Greena Index has ambitions to reshape the entire spectrum of the industry, from airlines to activities and destinations.Join us on a mission to transform the entire tourism industry for many generations to come.
Show all investments...

OTV
VC Fund · Tel Aviv, Tel Aviv, Israel · 1 investments in Middle East Life Science startups

OTV focuses on round A+ startups that aim to make a significant impact on people's lives. Our focus is on entrepreneurs with innovative ideas who are advancing the global state of well-being. Come join the digital health revolution, and be a part of transforming the healthcare industry.

Show more...

Investment focus

  • Industry: Health Care, Medical, Artificial Intelligence
  • Stage:Series A, Series B, Seed
  • Geography: United States, Israel, Ghana

Investor stats

  • Total investments: 21
  • Round size: Seed $5M–$8M; Series B $16M–$50M
  • Lead/follow: 57% lead, 43% follow
  • Last fund: May invest from a new fund soon — last raise in 2020

Portfolio highlights

  • Scopio — Buy & sell images on the largest Solana Photography NFT Marketplace. Find high-quality stock images & hire artists from around the world.
  • Scopio Labs — Click here to learn more about Scopio Labs AI Driven Digital Platform for Cell Morphology.
  • Stake — Renters earn Cash back for rent. Building operators outperform the market. That's the Stake win-win. Find out how we're building the financial tools for the next generation of rentals.
Show all investments...

Arc Impact
VC Fund · Haifa, Hefa, Israel · 1 investments in Middle East Life Science startups

Arc Impact is a venture capital firm.

Show more...

Investment focus

  • Industry: Health Care, AgTech, EdTech
  • Stage:Seed, Pre-Seed
  • Geography: Israel, United States, United Kingdom

Investor stats

  • Total investments: 7
  • Round size: Seed $2.5M–$6M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Behavidence — Behavidence is a mental health application that generates a daily mental health score. It compares your digital behavior to other people with anxiety, depression and ADHD.
  • MadeRight — We usher in a new era of sustainable fungi-based materials that deliver excellent performance. The future, as we see it, is a novel industrial chain based on biomaterials.
  • Virtual Internships — The only platform that provides guaranteed remote internships in your chosen industry and region to gain the skills employers seek.
Show all investments...

Alexandria Fund
VC Fund · 1 investments in Middle East Life Science startups

Alexandria Fund

Show more...

Investment focus

  • Industry: Biopharma, Life Science, Biotechnology
  • Stage:Seed
  • Geography: Egypt

Investor stats

  • Total investments: 1
  • Lead/follow: no public data

Portfolio highlights

  • Nawah Scientific — Nawah is MENA & Africa's first Cloud Lab providing Analytical and R&D services to the region's life science, food, agricultural and pharmaceutical sectors.
Show all investments...

M Ventures
VC Fund · Amsterdam, Noord-Holland, The Netherlands · 1 investments in Middle East Life Science startups, 17 in the past 12 months

Merck Ventures is the strategic, corporate venture capital arm of Merck. Its mandate is to invest in innovative technologies and products with the potential to significantly impact Merck‘s core business areas. From its headquarters in Amsterdam and offices in the US and Israel we invest globally in transformational ideas driven by greatentrepreneurs. Merck Ventures takes an active role in its portfolio companies and teams up with entrepreneurs and co-investors to translate innovation towards commercial success. Merck Ventures has a significant focus on early-stage investing and company creation including the creation of spin-offs to leverage Merck‘s science and technology base.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series A, Series B, Seed
  • Geography: United States, Switzerland, United Kingdom

Investor stats

  • Total investments: 119
  • Round size: Seed $2.1M–$18M; Series A $6M–$42M; Series B $9.5M–$67M
  • Lead/follow: 39% lead, 61% follow

Portfolio highlights

  • CellFE — CellFE is a company developing a microfluidics based device to deliver gene-editing molecules. CellFE developed microfluidic device and process that can efficiently deliver gene-editing molecules into the human cells.
  • BeeOLED — BeeOLED’s technology enables OLED displays with significantly improved efficiency, brightness and operational stability at lower overall costs due to a less complex device structure.
  • Lightcast Discovery — Flexible control over droplet number, occupancy, location and movement. Enabling efficient, multi-step workflows with unprecedented flexibility.
Show all investments...

Office of the Chief Scientist
VC Fund · Tel Aviv, Tel Aviv, Israel · 1 investments in Middle East Life Science startups

The Office of the Chief Scientist [OCS] in the Ministry of Economy is charged with execution of government policy for support of industrial R&D. The goal of the OCS is to assist in the development of technology in Israel as a means of fostering economic growth, encouraging technological innovation and entrepreneurship, leveraging Israel’sscientific potential, enhancing the knowledge base of industry in Israel, stimulating high value-added R&D and encouraging R&D collaboration both nationally and internationally. A variety of ongoing support programs developed and offered by the OCS play a major role in enabling Israel to be a key center for high tech entrepreneurship.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Hardware
  • Stage:Seed
  • Geography: Israel

Investor stats

  • Total investments: 3
  • Round size: Seed $1M–$1M
  • Lead/follow: 33% lead, 67% follow

Portfolio highlights

  • LapSpace — LapSpace Medical was founded in 2011. It operates within the framework of the Misgav Venture Accelerator, part of The Trendines Group. The LapSpace team combines strong business and medical experience and knowledge.
  • Digma Medical — Digma Medical | DiaGone - safe, one-time, 30 minute, minimaly-invasive, GI procedure for Restoring Glycemic Control for T2DM & NASH patients | No Implant
  • Immunovative Therapies — Immunovative Therapies is a biopharmaceutical company with financial support of the Israel Office of the Chief Scientist. ITL is a graduate of the Misgav Venture Accelerator, a member of the world renown Israel technological incubator program. The company was the Misgav Venture Accelerator's candidate for the prize for the outstandingincubator project of 2006, awarded by the Office of the Chief Scientist. They specialize in the development of novel immunotherapy drug products that incorporate living immune cells as the active ingredients for the treatment of cancer and infectious disease.
Show all investments...

RMGP Biopharma Investment Fund
VC Fund · 1 investments in Middle East Life Science startups

RMGP Biopharma Investment Fund is an investment Fund

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Pharmaceutical
  • Stage:Series B
  • Geography: Israel

Investor stats

  • Total investments: 3
  • Lead/follow: no public data

Portfolio highlights

  • Ramino Bio — Ramino Bio is a private biotech company that develops an oral drug to treat metabolic diseases.Ramino has received funding totaling about $3.3 million since its beginning from the FutuRx biotech incubator, which is supported by the Israeli Innovation Authority, Takeda, J&J, OrbiMed, and RMPG. By speeding up their disintegration, our exclusivetechnology lowers the extra BCAA that is floating around.
  • Pi Therapeutics — Pi Therapeutics is a discovery-stage biopharmaceutical company aiming to develop a novel cancer drug. The company is financed by a syndicate of Takeda Pharmaceutical Company through its venture group Takeda Ventures Inc., Johnson & Johnson Innovation – JJDC, OrbiMed Israel Partners, Pontifax, and the Israel Innovation Authority, and hasoperated since March 2015 in the FutuRx biotech accelerator in Ness Ziona, Israel. The company’s mission is to develop novel first-in-class drugs directed against the ubiquitin-proteasome system (UPS), mainly for treatment of cancer.
  • Protekt Therapeutics — ProteKt Therapeutics is a drug development company aiming to develop potent and selective oral inhibitors of the kinase PKR for the treatment of neurodegenerative and neuroinflammatory diseases. The company has raised a $4M pre-A round and graduated from the FutuRx accelerator in 2019.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Milk and Honey Investments
VC Fund · 1 investments in Middle East Life Science startups

The Land of Milk and Honey is an abundant location where life is simple and devoid of need. Both in brand-new real estate development projects and while professionally restoring and renovating houses, Milk and Honey Investments LLC aims to create distinctive spaces of abundance and healthy living.

Show more...

Investment focus

  • Industry: Life Science, Organic Food, Biotechnology
  • Stage:Series A
  • Geography: Israel

Investor stats

  • Total investments: 1
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • BioBetter — BioBetter is a foodtech company that develops plant-based platforms for the production of complex growth factors used in cultivated meat. The company was founded in 2015 and is headquartered in Israel.
Show all investments...

Emirates Angels
VC Fund · 1 investments in Middle East Life Science startups

investing in the future.

Show more...

Investment focus

  • Industry: Health Care, Life Science
  • Stage:Pre-Seed
  • Geography: United Arab Emirates

Investor stats

  • Total investments: 1
  • Lead/follow: 100% lead, 0% follow

Portfolio highlights

  • Takalam — Takalam is an online counseling platform for a digital solution for mental well-being.
Show all investments...

Aries Holding BV
VC Fund · Amsterdam, Noord-Holland, The Netherlands · 1 investments in Middle East Life Science startups

financial holding company / investments

Show more...

Investment focus

  • Industry: FinTech, Finance, Payments
  • Stage:Seed, Pre-Seed
  • Geography: The Netherlands, Israel

Investor stats

  • Total investments: 4
  • Lead/follow: no public data

Portfolio highlights

  • Wakuli — It's called specialty coffee. Roasted lighter to enhance all the exciting flavours. To really taste them it's important to drink fresh. That's why we send our mailbox-friendly coffee within one week after roasting. And always with a better price for the farmers - thanks to you.
  • Diptera — Developing technology to fight mosquitoes with mosquitoes.
  • Flow — Flow is FinTech 3.0: It let's you automate payments between your bank accounts and wallets. Based on triggers and actions you can transfer your money automatically to the accounts you choose. Use Flow to automate a budgetting system, your investing, buying crypto or to distribute your money the way you like it. Where the previous generationpayment companies needed to build and maintain expensive payment rails, Flow focusses on leveraging Open Banking. People trust Flow to help with their cashflow automation.
Show all investments...

Stony Hill Corp
VC Fund · Beverly Hills, California, United States · 1 investments in Middle East Life Science startups

A Diversified Company focused on multiple area of the cannabis hemp and CBD industry.

Show more...

Investment focus

  • Industry: AgTech, Medical, Cannabis
  • Stage:Series A
  • Geography: Israel

Investor stats

  • Total investments: 1
  • Lead/follow: 100% lead, 0% follow

Portfolio highlights

  • GemmaCert — The easy-to-use GC-PRO by GemmaCert for quick and accurate potency analysis of cannabis and hemp, including for THC, CBD, and CBG.
Show all investments...

Arba Finance Ltd.
VC Fund · 1 investments in Middle East Life Science startups

Investment banking boutique based in Tel Aviv since 1978.

Show more...

Investment focus

  • Industry: AgTech, Medical, Cannabis
  • Stage:Series A
  • Geography: Israel

Investor stats

  • Total investments: 1
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • GemmaCert — The easy-to-use GC-PRO by GemmaCert for quick and accurate potency analysis of cannabis and hemp, including for THC, CBD, and CBG.
Show all investments...

Nowaisi Investments
VC Fund · 1 investments in Middle East Life Science startups

Nowaisi Investments

Show more...

Investment focus

  • Industry: Health Care, Life Science
  • Stage:Pre-Seed
  • Geography: United Arab Emirates

Investor stats

  • Total investments: 1
  • Lead/follow: no public data

Portfolio highlights

  • Takalam — Takalam is an online counseling platform for a digital solution for mental well-being.
Show all investments...

Grove Ventures
VC Fund · Tel Aviv, Tel Aviv, Israel · 1 investments in Middle East Life Science startups, 7 in the past 12 months

Grove Ventures is a leading early-stage venture capital fund in Israel. It partners early with exceptional Israeli founders who believe th...

Show more...

Investment focus

  • Industry: Artificial Intelligence, Machine Learning, Software
  • Stage:Seed, Series A, Series B
  • Geography: Israel, United States

Investor stats

  • Total investments: 45
  • Round size: Seed $3.3M–$9M; Series A $5.5M–$23M; Series B $25M–$74M
  • Lead/follow: 51% lead, 49% follow
  • Last fund: Likely still investing — raised $185M in 2022

Portfolio highlights

  • NoTraffic — NoTraffic has developed the first AI-powered traffic signal platform that connects road...
  • Wing Cloud — Wing Cloud tames cloud complexity through a unified programming and operational model that works across all providers and services.
  • DeepChecks — Continuous validation for machine learning. Validate and monitor your data and models during training, production and new version releases.
Show all investments...

Hult Alumni Angels
VC Fund · 1 investments in Middle East Life Science startups

Hult Alumni Angels

Show more...

Investment focus

  • Industry: Biopharma, Life Science, Biotechnology
  • Stage:Seed
  • Geography: Egypt

Investor stats

  • Total investments: 1
  • Lead/follow: no public data

Portfolio highlights

  • Nawah Scientific — Nawah is MENA & Africa's first Cloud Lab providing Analytical and R&D services to the region's life science, food, agricultural and pharmaceutical sectors.
Show all investments...

Jerusalem Venture Partners (JVP)
VC Fund · Jerusalem, Yerushalayim, Israel · 1 investments in Middle East Life Science startups

Investment strategy is spearheaded by a deep expertise in identifying companies from inception and building global industry leaders.

Show more...

Investment focus

  • Industry: Software, Cyber Security, Enterprise Software
  • Stage:Series A, Series B, Seed
  • Geography: United States, Israel, United Kingdom

Investor stats

  • Total investments: 161
  • Round size: Seed $1.5M–$6M; Series A $3.2M–$25M; Series B $10M–$20M
  • Lead/follow: 43% lead, 57% follow
  • Last fund: May invest from a new fund soon — last raise in 2019

Portfolio highlights

  • Akeyless Security — Akeyless Vault platform built to secure IT and DevOps resources, credentials, and access, on hybrid cloud and legacy environments.
  • BioBetter — BioBetter is a foodtech company that develops plant-based platforms for the production of complex growth factors used in cultivated meat. The company was founded in 2015 and is headquartered in Israel.
  • Chain Reaction — Chain Reaction is engineering the future of disruptive blockchain and privacy technologies by accelerating compute and mining hardware performance.
Show all investments...

aMoon Fund
VC Fund · Ra'anana, HaMerkaz, Israel · 1 investments in Middle East Life Science startups

aMoon is a leading healthtech & life sciences venture capital firm.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Series B
  • Geography: United States, Israel, United Kingdom

Investor stats

  • Total investments: 49
  • Round size: Series A $6M–$63M; Series B $30M–$35M
  • Lead/follow: 59% lead, 41% follow
  • Last fund: May invest from a new fund soon — raised $7.3M in 2019

Portfolio highlights

  • Theranica — Theranica is a medical device company that has combined neuromodulation therapy with modern wireless technology to develop proprietary wearable solutions that address various medical conditions and disease states. The noninvasive and therapeutic 'smart' patches are controlled by a smartphone app to allow for personalized, portable, andaffordable care. The patch consists of a proprietary 'smart' chip that delivers electrical pulses to neuro-modulate the sensory nerves under the skin. The first application of the technology is for treatment of migraine headaches.
  • Eleos Health — Eleos Health provides automated health tech solutions that accelerate clinicians’ decision-making via an AI-powered Speech-to-Insights system to ensure the provision of personalized and time and cost-effective care.
  • Ultima Genomics — Ultima Genomics, Inc is revolutionizing DNA sequencing technology with the UG100 by providing scalability for the $100 genome
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
NextLeap Ventures
VC Fund · Herzliya, Tel Aviv, Israel · 1 investments in Middle East Life Science startups

NextLeap Ventures offers investors the opportunity to invest in early stage, Israeli high-tech startups, selected through its unique, highly vetted process.

Show more...

Investment focus

  • Industry: Software, Big Data, Health Care
  • Stage:Seed, Series A
  • Geography: Israel, United States

Investor stats

  • Total investments: 14
  • Round size: Seed $900k–$5M
  • Lead/follow: 21% lead, 79% follow

Portfolio highlights

  • Cybord — Cybord develops technologies that stop counterfeit, defective and malicious electronic components from getting assembled into products during the manufacturing process. Cybord scans each component prior to placement by integrating with electronic product manufacturing equipment, and deep learning algorithms rate each component based on Cybord’sglobal component database. Between 5 to 10% of all electronic components are considered counterfeit, responsible for up to 35% of RMAs. With Cybord, OEMs, EMSs, and distributors ensure their products are of high quality and free of hardware-cyber threats
  • Enzymit — Enzymit's platform technology can build molecular machines that enable never before seen chemistry aiming to solve humanity's greatest challenges
  • ShieldIOT — ShieldIOT delivers innovative cybersecurity solutions that protect edge devices from security threats and operational risks. Their application-agnostic software solution enables device manufacturers and network operators to automatically secure existing and new devices, across multiple industries, with no need for any development resources orsecurity expertise.
Show all investments...

Trendlines Group
VC Fund · Misgav, HaZafon, Israel · 1 investments in Middle East Life Science startups

Trendlines Group invents, discovers, invests in, and incubates innovation-based medical and agrifood technologies. Trendlines invests principally through medical and agrifood incubators in Israel and in Singapore, its in-house innovation center, Trendlines Labs, and its Funds - the Trendlines Agrifood Fund and the Bayer Trendlines Ag InnovationFund.The company was founded in 1993 and is headquartered in Misgav, Israel.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical Device
  • Stage:Seed, Series A
  • Geography: Israel, Singapore, United Kingdom

Investor stats

  • Total investments: 56
  • Round size: Seed $500k–$3M; Series A $2.3M–$7.5M
  • Lead/follow: 22% lead, 78% follow
  • Last fund: May invest from a new fund soon — last raise in 2019

Portfolio highlights

  • Insectta — Insectta was founded in 2017 and produces materials from insects which can be applied across industries such as agrifood, pharmaceutical and electronics.
  • Celleste Bio — Celleste is a business that specializes in employing cell culture techniques to produce high-value cocoa ingredients, removing the need for cocoa trees to be grown.
  • PlanetWatchers — Highly accurate crop growth, wind, hail and flood damage assessments at scale. Supporting the crop insurance industry with acreage and claims validation.
Show all investments...

Clal Biotechnology Industries
VC Fund · Tel Aviv, Tel Aviv, Israel · 1 investments in Middle East Life Science startups

Clal Biotechnology Industries is a leading Israeli life sciences investment company traded on the Tel Aviv Stock Exchange (TASE: CBI)

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Series B
  • Geography: Israel, United States

Investor stats

  • Total investments: 14
  • Round size: Series A $4M–$55M
  • Lead/follow: 14% lead, 86% follow

Portfolio highlights

  • Sight Diagnostics — Combining AI and breakthrough hardware to bring lab-quality CBC results to the doctor's office.
  • Cadent Therapeutics — Cadent Therapeutics is a precision neuroscience company developing novel medicines that tune and modulate brain rhythms to restore cognitive and motor function in patients with serious neurological disease. The company leverages its precision neuroscience approach combining target specificity, patient selection, drug design and optimization, andnovel quantitative endpoints to create first-in-class molecules to treat movement and cognitive disorders.It was founded in 2010 and headquartered in Cambridge, Massachusetts.
  • Elicio Therapeutics — Elicio ground-breaking Amphiphile technology is engineering potent vaccines and immunotherapies to defeat an array of aggressive cancers.
Show all investments...

Alex Angels
VC Fund · Alexandria, Al Iskandariyah, Egypt · 1 investments in Middle East Life Science startups

Alex Angels is an investment management company that helps investors to invest in early-stage companies with strong management teams. The company specializes in the fields of financial services, financial exchange, and investments. Alex Angels was founded in 2016 and headquartered in Al Iskandariyah, Egypt.

Show more...

Investment focus

  • Industry: E-Commerce, Marketplace, Mobile Apps
  • Stage:Seed, Pre-Seed, Convertible Note
  • Geography: Egypt

Investor stats

  • Total investments: 22
  • Round size: Seed $100k–$1.2M; Pre-Seed $28k–$100k
  • Lead/follow: 50% lead, 50% follow
  • Last fund: May invest from a new fund soon — last raise in 2020

Portfolio highlights

  • CardoO — Welcome To Our InnovationsExplore
  • SIDEUP — SIDEUP provides you with all the necessary tools to grow your business through a hassle-free experience from local and global logistics support, storage services, and innovative and real-time dashboards.
  • Suplyd — Suplyd is a comprehensive digital solution that bridges the gap between restaurant operators and their suppliers in order to disrupt an untouched market with extreme fragmentation and resolve the problem end-to-end.
Show all investments...

First Star Ventures
VC Fund · Boston, Massachusetts, United States · 1 investments in Middle East Life Science startups

Investing with conviction in visionary, technical founders inventing the future.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Machine Learning
  • Stage:Seed, Pre-Seed, Series A
  • Geography: United States, Canada, Israel

Investor stats

  • Total investments: 48
  • Round size: Seed $895k–$8.5M; Pre-Seed $1.2M–$1.8M; Series A $4.2M–$13M
  • Lead/follow: 14% lead, 86% follow
  • Last fund: Likely still investing — fund raised in 2022

Portfolio highlights

  • Robigo — Engineering the plant microbiome for a more sustainable food system
  • Genialis — Genialis is a precision medicine data science company focused on new ways to treat disease. Blending computational biology and AI-based methods, Genialis merges and models data at the intersection of clinical and translational medicine and drug discovery. Genialis is trusted by biopharma and big pharma alike, to validate targets, predict biomarkersand optimally position novel drugs. Together, Genialis and its partners are bringing improved solutions to drug discovery to change people's lives.
  • Blumen Systems — Blumen is an early-stage technology company building software to streamline the regulatory challenges associated with upstream natural resources production in the US. We are focused on producers building and utilizing land-based assets powering the energy transition including carbon sequestration, geothermal, critical minerals, hydrogen, and RNGprojects.
Show all investments...

Ibtikar Fund
VC Fund · Ramallah, West Bank, Palestinian Territory · 1 investments in Middle East Life Science startups

Ibtikar (Innovation, in Arabic) is a disruptive fund that will invest in innovative Palestinian companies. Ibtikar’s investments begin at the seed level through local accelerators, continue in post-acceleration phases and can also include series A investments in its portfolio companies. Through this investment strategy we aim to close a criticalfunding gap between acceleration and VC and other later-stage investors. Our goal is to maximize return for our investors by helping high-potential Palestinian companies answer regional and global needs. We will do this through direct support from our management team and select group of advisors, and will leverage the strong network of our investors and partners for the benefit of each of our portfolio companies.

Show more...

Investment focus

  • Industry: E-Commerce, Artificial Intelligence, Health Care
  • Stage:Seed, Pre-Seed
  • Geography: Palestinian Territory, United States, Jordan

Investor stats

  • Total investments: 26
  • Round size: Seed $150k–$600k; Pre-Seed $60k–$250k
  • Lead/follow: 65% lead, 35% follow
  • Last fund: Likely still investing — fund raised in 2022

Portfolio highlights

  • Vatrin — Vatrin provides an easy way for small-business owners to set up a simple website to facilitate online orders, payments and a direct connection to WhatsApp for managing and tracking the final order.
  • DataQueue — Unlock the true power of artificial intelligence with DataQueue. Our platform offers a transformative approach to AI lifecycle management, providing end-to-end solutions that cover every step of the process. From data labeling and automation to deployment and human-in-the-loop integration, we have
  • Alma Health — Alma Health is a digitally-native chronic illness management platform serving an addressable market of 20m patients in GCC. Through its cloud pharmacy and virtual doctor consultations, Alma Health is translating patient behavior and insights into personalized services and products like digital treatments and at home monitoring systems. Alma Healthis based in Hub71-Abu Dhabi.
Show all investments...

HBL Hadasit Bio Holdings
VC Fund · Jerusalem, Yerushalayim, Israel · 1 investments in Middle East Life Science startups

Hadasit Bio-Holdings Ltd. ("HBL") was founded and floated on the Tel Aviv Stock Exchange (TASE : HDST ) and recently on the OTC (OTCBB : HADSY ) in order to allow public participation in the highly promising field of biotechnology.It serves as a precedent in biotech financing - for the first time, public investment is allowed toparticipate in a holding entity including companies based on IP generated by Israel’s foremost medical research center – Hadassah University Hospital ("HU").In addition to the public holdings (54%) – including major Israeli institutional investors, HBL is held by Hadasit (www.hadasit.co.il) (36%) and Consensus Business Group (http://www.consensusbusiness.com) (10%). The traded stock, as a unique investment vehicle, provides investment exposure to a select cluster of 6 biotech companies - all based on inventions developed and owned by HU.HBL is a publicly traded subsidiary of Hadasit Ltd. – the technology transfer company of the Hadassah University Hospital in Jerusalem, Israel. Hadasit was established for the purpose of promoting and commercializing the intellectual property (IP) and R&D capabilities generated by Hadassah, aimed at finding solutions to problems faced by modern medicine.

Show more...

Investment focus

  • Industry: Biotechnology, Medical, Health Care
  • Stage:Series A, Series B
  • Geography: Israel

Investor stats

  • Total investments: 9
  • Lead/follow: 11% lead, 89% follow

Portfolio highlights

  • ProtAb — ProtAb develops therapeutic agents that modulate cytokine regulation, tipping the balance toward anti-inflammatory signaling pathways in the treatment of autoimmune and inflammatory diseases. Its first product, Prozumab, is a monoclonal antibody with a novel mechanism of action. It is currently in late-stage preclinical development for thetreatment of inflammatory bowel disease or IBD, ulcerative colitis or UC, and rheumatoid arthritis or RA. It operates as a subsidiary of Hadasit Bio-Holdings. HBL is a publicly traded subsidiary of Hadasit, the technology transfer company of the Hadassah University Hospital in Jerusalem in Israel.
  • KAHR medical — KAHR Medical ("KAHR") is pioneering the development of "third generation biological drugs," a unique class of proprietary fusion-protein molecules with clear and far-reaching advantages. KAHR's technology represents a paradigm shift in protein-based pharmaceuticals that will significantly expand available treatment optionsfor cancer and autoimmune disorders.
  • Enlivex Therapeutics — Enlivex is a clinical-stage macrophage reprogramming immunotherapy company that targets diseased macrophages in patients with sepsis. The company develops an autologous and allogeneic drug pipeline for the treatment of autoimmune and inflammatory conditions such as Graft versus Host Disease (GvHD), solid organ transplant rejection, Crohn'sDisease, and other autoimmune and inflammatory disorders.The company's revolutionary approach is to induce immune tolerance by injecting apoptotic cells and facilitating their interaction with dendritic cells activates the body's innate, physiologic mechanism for down-regulating inflammation and autoimmunity.Enlivex is an Israeli-based cell immunotherapy company established in October 2005 by Professor Dror Mevorach, a world-renowned expert on clearance of dying (apoptotic) cells.
Show all investments...

Forbion Capital Partners
VC Fund · Naarden, Noord-Holland, The Netherlands · 1 investments in Middle East Life Science startups, 8 in the past 12 months

Impacting the future of medicine.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series B, Series A, Series C
  • Geography: United States, United Kingdom, The Netherlands

Investor stats

  • Total investments: 118
  • Round size: Series A $4.5M–$30M; Series B $12M–$115M; Series C $5.6M–$65M
  • Lead/follow: 46% lead, 54% follow
  • Last fund: Likely still investing — fund raised in 2023

Portfolio highlights

  • Mariana Oncology — Mariana Oncology is a biotechnology research industry.
  • Seamless Therapeutics — Seamless Therapeutics is changing the paradigm of gene editing through a pioneering approach to restore health in patients with severe conditions in a safe and precise manner. Seamless technology platform unlocks the reprogramming of recombinases, a highly versatile class of enzymes.
  • Complement Therapeutics — Turning powerful new Complement System insights into innovative treatments Developing the next generation of complement medicines [chevron-down] Turning powerful new Complement System insights into innovative treatments Developing the next generation of complement medicines [chevron-down] Geographic atrophy (late dry age-related macular degeneration) is a chronic eye condition that affects millions - and for which there is
Show all investments...

Almoayed Ventures
VC Fund · Manama, Al Manamah, Bahrain · 1 investments in Middle East Life Science startups

Almoayed Ventures is the venture arm of Almoayed General W.L.L. The company focuses on partnering with investment professionals with a track record of supporting and scaling innovative businesses. The company also makes direct investments in passionate entrepreneurs and supports them throughout their journey.

Show more...

Investment focus

  • Industry: Health Care, Information Technology, Financial Services
  • Stage:Seed, Series A, Pre-Seed
  • Geography: United States, India, United Arab Emirates

Investor stats

  • Total investments: 15
  • Round size: Seed $1.2M–$13M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • BizzTM — BizzTM is a company that provides a variety of e-commerce categories of products through an aggregated delivery model.
  • Ridepanda — Employer sponsored leases on the widest selection of pedal bikes, e-bikes and e-scooters from top brands.
  • Alma Health — Alma Health is a digitally-native chronic illness management platform serving an addressable market of 20m patients in GCC. Through its cloud pharmacy and virtual doctor consultations, Alma Health is translating patient behavior and insights into personalized services and products like digital treatments and at home monitoring systems. Alma Healthis based in Hub71-Abu Dhabi.
Show all investments...

Boehringer Ingelheim Venture Fund
VC Fund · Ingelheim Am Rhein, Rheinland-Pfalz, Germany · 1 investments in Middle East Life Science startups

The Boehringer Ingelheim Venture Fund is the strategic venture fund of the Boehringer Ingelheim Corporation.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series A, Series B, Seed
  • Geography: United States, Germany, Belgium

Investor stats

  • Total investments: 82
  • Round size: Seed $1.3M–$14M; Series A $3.8M–$29M; Series B $11M–$50M
  • Lead/follow: 49% lead, 51% follow
  • Last fund: May invest from a new fund soon — last raise in 2018

Portfolio highlights

  • DiogenX — We incorporated DiogenX with the objective to provide new therapeutic solutions for diabetic patients. With Patrick Collombat and the team, we are focused on developing a first-in-class regenerative treatment for type 1 diabetes. Benjamin Charles CEO See the team News See more Our Work OUR APPROACH ABOUT DIABETES
  • smartbax — We develop novel multi-targeted, antibacterial compounds with extraordinary potency against multi-drug resistant bacteria and difficult-to-treat biofilms.
  • Rewind Therapeutics — Rewind Therapeutics is a developer of novel therapeutics intended to facilitate the treatment for neurological diseases.The company's first-in-class remyelinating therapeutics block inhibitory signals that prevent the expansion and migration of oligodendrocyte stem cells in order to promote effective remyelination, enabling medicalpractitioners to treat patients suffering from multiple sclerosis and other myelin-related diseases with efficacy.
Show all investments...

FAQ

Is Shizune data fresh/accurate?

Shizune has monitored hundreds of funding sources since 2020.

Our investor database is updated every day, so investor data is always fresh.

All metrics are calculated from confirmed public rounds, so the data is accurate.

Can I download investor list?

To download the Life Science VC Funds in Middle East investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.

You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.

Can I access investor database?

To access all 48,091 VC funds investing in Middle East Life Science startups and 48,091+ more investors, create a Shizune account.

Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.

The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.

You can enrich with email and download the data.

Does Shizune have investor emails and contacts?

Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.

To guarantee the highest discovery rate, we search across 20+ contact search tools.

To maximize delivery rate and reduce bounce rate, we validate emails.

You can enrich your investor list with Shizune. Download it too.

What is Shizune?

Shizune is a 48,091 investor database updated daily.

With Shizune you can:

  • browse the database
  • use smart matching
  • enrich with emails
  • download

All you need to find investors for your startup.

Who is Shizune for?

Shizune is built for startup founders by startup founders.

If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.

Is Shizune free?

Shizune is free forever. You can search and browse investors for free.

Email search and export are paid features.

For full info, visit our pricing.

Who built Shizune?

Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.

Contact 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!

More investor lists

Broader lists